PharmEng International, Inc. has appointed John Durham as corporate vice president, business development for Keata Pharma, Inc., a wholly owned subsidiary of PharmEng. Keata has pharmaceutical contract manufacturing facilities in Arnprior, ON and new facilities in Sydney, Nova Scotia that provide formulation development and testing services to manufacture and package products in solid and liquid dosage forms, including aseptic manufacturing.     Prior to joining the company, Mr. Durham was pr...